glp-1 breast cancer recurrence Receptor Agonists Linked to Improved Survival Outcomes in GLP-1 receptor agonists (GLP-1 RAs)

Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue by mimicking ghrelin at the GH secretagogue receptor [1] [2]

Date published: 2024-09-12 Rated 4 out of 5 by Susan B

Although preliminary findings indicate that GLP-1Ra causes modest BMD reduction and enhances bone remodeling, favoring resorption similar to the effects of calorie restriction, further research is needed

Vitaly Pozdeev (Uni.Lu), Dominique Revets (LIH), Thomas Cerutti (LIH), and Gert Van Isterdael (VIB) for tissue section microscopy and FACS sorting

Finally, we are interested in better understanding how the market for these compounded products has changed since the FDA declared an end to the shortages of semaglutide and tirzepatide.